Pacs Investors Have Opportunity to Lead Pacs Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against PACS Group, Inc. for violations of federal securities laws related to misleading statements and fraudulent activities during its IPO and subsequent period [1][5]. Group 1: Lawsuit Details - The lawsuit is initiated by the Schall Law Firm, targeting PACS Group, Inc. for allegedly making false and misleading statements to the market [1][5]. - Investors who purchased PACS securities during the IPO on April 11, 2024, or between April 11, 2024, and November 5, 2024, are encouraged to contact the firm [2]. - The class period for the lawsuit has not yet been certified, meaning potential class members are not yet represented by an attorney [4]. Group 2: Allegations Against PACS - The complaint alleges that PACS engaged in a fraudulent Medicare claim scheme, which accounted for over 100% of its operating and net income from 2020 to 2023 [5]. - The company is accused of billing Medicare for thousands of unnecessary therapies and falsifying documentation related to licensure and staffing [5]. - As a result of these actions, PACS's public statements were deemed false and materially misleading, leading to investor damages when the truth was revealed [5].